Laduviglusib

[1]Ring DB, et al. Selective glycogen synthase kinase 3 inhibitors potentiate activation of glucose transport and utilization in vitro and in vivo. Diabetes. 2003 Mar;52 (3) :588-95.|[2]Bennett CN, et al. Regulation of Wnt signaling during adipogenesis. J Biol Chem. 2002 Aug 23;277 (34) :30998-1004.|[3]Naujok O, et al. Cytotoxicity and activation of the Wnt/beta-catenin pathway in mouse embryonic stem cells treated with four GSK3 inhibitors.BMC Res Notes. 2014 Apr 29;7:273.|[4]Wang X, et al. Pharmacologically blocking p53-dependent apoptosis protects intestinal stem cells and mice from radiation. Sci Rep. 2015 Apr 10;5:8566.|[5]Ye S, et al. Pleiotropy of glycogen synthase kinase-3 inhibition by CHIR99021 promotes self-renewal of embryonic stem cells from refractory mouse strains. PLoS One. 2012;7 (4) :e35892.

Biochemistry and Cell Biology. Rice University. 2019 May.|ACS Chem Neurosci. 2018 Dec 19;9 (12) :3175-3185. |ACS Nano. 2025 Jan 14;19 (1) :345-368.|ACS Nano. 2025 Sep 23;19 (37) :33567-33586.|Acta Neuropathol Commun. 2025 May 27;13 (1) :118.|Acta Pharm Sin B. 2024 Apr 24.|Acta Pharm Sin B. 2025 Sep 19.|Acta Pharmacol Sin. 2024 Nov;45 (11) :2290-2299.|Acta Pharmacol Sin. 2025 Nov 1.|Adv Sci (Weinh) . 2022 Sep;9 (26) :e2202505.|Adv Sci (Weinh) . 2024 Dec 4:e2408852.|Adv Sci (Weinh) . 2024 Mar;11 (11) :e2305992.|Adv Sci (Weinh) . 2025 Nov 3:e09151.|Adv Sci (Weinh) . 2025 Nov 7:e12325.|Adv Sci (Weinh) . 2025 Sep 3:e05270.|Adv Sci (Weinh) . 2025 Sep 9:e13476.|Am J Physiol Cell Physiol. 2023 Jul 1;325 (1) :C344-C361.|Animals (Basel) . 2024 May 4;14 (9) :1382.|Ann Hematol. 2023 Nov;102 (11) :3153-3165.|Antioxidants (Basel) . 2022 Jan 29;11 (2) :274.|Antiviral Res. 2024 Jun:226:105891.|APMIS. 2025 Nov;133 (11) :e70078.|Biochem Biophys Res Commun. 2018 Sep 5;503 (2) :1123-1129.|Biochem Biophys Res Commun. 2020 Apr 2;524 (2) :280-287.|Biochem Biophys Res Commun. 2022 Jan 29:590:125-131.|Biochim Biophys Acta Mol Basis Dis. 2025 May 13:167904.|Bioengineering (Basel) . 2023 Jun 9;10 (6) :702.|Biol Reprod. 2025 May 13:ioaf108.|Biomater Res. 2025 Nov 7:29:0280.|Biomater Res. 2025 Oct 22.|Biomaterials. 2018 Oct;180:12-23.|Biomaterials. 2024 Jul 1:311:122691.|Biomaterials. 2018 Dec 6;193:30-46.|Biomedicines. 2022 Apr 18;10 (4) :928. |bioRxiv. 2023 Aug 14.|bioRxiv. 2023 Jun 28.|bioRxiv. 2024 Dec 6:2024.12.06.627179.|bioRxiv. 2024 Feb 2.|bioRxiv. 2024 June 27.|bioRxiv. 2024 Mar 1.|bioRxiv. 2024 Mar 12.|bioRxiv. 2024 Mar 14:2024.03.13.584912.|bioRxiv. 2024 November 15.|bioRxiv. 2025 April 14.|bioRxiv. 2025 April 21.|bioRxiv. 2025 April 26.|bioRxiv. 2025 Aug 07.|bioRxiv. 2025 Aug 19.|bioRxiv. 2025 Mar 31:2025.03.31.646367.|bioRxiv. 2025 March 21.|bioRxiv. 2025 March 25.|bioRxiv. 2025 May 14:2025.05.11.653328.|BMC Oral Health. 2024 Nov 21;24 (1) :1421.|Cancer Biol Med. 2020 Aug 15;17 (3) :707-725.|Cancer Lett. 2024 Jul 31:217147.|Cancer Res. 2025 Aug 29.|Cancers (Basel) . 2021 Mar 3;13 (5) :1079.|Cancers (Basel) . 2025 Feb 5;17 (3) :533.|Cardiovasc Toxicol. 2025 Aug 21.|Cell Biochem Funct. 2024 Sep;42 (7) :e4120.|Cell Biol Int. 2022 Dec;46 (12) :2198-2206.|Cell Biol Toxicol. 2025 Aug 20;41 (1) :126.|Cell Commun Signal. 2025 Jul 1;23 (1) :312.|Cell Death Differ. 2020 Jul;27 (7) :2158-2175. |Cell Death Dis. 2020 Mar 30;11 (3) :206.|Cell Death Dis. 2022 Mar 30;13 (3) :284.|Cell Death Dis. 2025 Mar 12;16 (1) :170.|Cell Death Discov. 2021 Oct 2;7 (1) :271.|Cell Death Discov. 2024 Mar 9;10 (1) :123.|Cell Discov. 2023 Jun 6;9 (1) :53.|Cell Metab. 2024 Jun 18:S1550-4131 (24) 00189-X.|Cell Mol Life Sci. 2025 Apr 6;82 (1) :139.|Cell Mol Life Sci. 2025 May 28;82 (1) :218.|Cell Prolif. 2021 Jan;54 (1) :e12932.|Cell Prolif. 2022 Apr;55 (4) :e13209.|Cell Prolif. 2023 Dec;56 (12) :e13498.|Cell Prolif. 2024 Jun;57 (6) :e13599.|Cell Regen. 2020 Sep 3;9 (1) :15.|Cell Rep Med. 2020 Dec 22;1 (9) :100161.|Cell Rep Med. 2024 May 21;5 (5) :101520.|Cell Rep. 2021 Nov 2;37 (5) :109949.|Cell Rep. 2022 Mar 29;38 (13) :110570.|Cell Reprogram. 2017 Dec;19 (6) :363-371.|Cell Signal. 2016 Mar;28 (3) :148-56. |Cell Signal. 2023 Jan:101:110526.|Cell Signal. 2025 Nov:135:112012.|Cell Stem Cell. 2022 Jul 7;29 (7) :1102-1118.e8.|Cell Stem Cell. 2022 Sep 1;29 (9) :1366-1381.e9.|Cell Stem Cell. 2025 Aug 29;32 (10) :1509-1527.e9|Cell Stem Cell. 2025 Jul 3;32 (7) :1071-1086.e8.|Cell. 2024 Nov 14;187 (23) :6566-6583.e22.|Cells Dev. 2021 Jun:166:203665.|Cells Dev. 2024 Sep 5:203970.|Chem Biol Interact. 2025 Apr 25:411:111421.|Chem Eng J. 1 January 2023, 138737.|Chemosphere. 2019 Feb:216:372-378.|Commun Biol. 2024 Apr 29;7 (1) :510.|Commun Biol. 2025 Feb 26;8 (1) :310.|Comp Biochem Physiol C Toxicol Pharmacol. 2025 Oct 11:299:110373.|Curr Biol. 2020 Nov 2;30 (21) :4128-4141.e5.|Curr Protoc Cell Biol. 2018 Dec;81 (1) :e62.|Curr Res Neurobiol. 2023 Jun 17:5:100095.|Dev Cell. 2025 Jul 21;60 (14) :2007-2022.e7.|Discov Oncol. 2025 Jan 20;16 (1) :63.|EMBO Rep. 2023 Aug 3;24 (8) :e57499.|Environ Toxicol. 2017 Oct;32 (10) :2316-2322.|Eur J Pharm Sci. 2021 Dec 1:167:106003.|Exp Cell Res. 2022 Nov 11;422 (1) :113416.|Exp Eye Res. 2025 May 21:110440.|Exp Ther Med. 2020 Mar;19 (3) :1701-1710.|FASEB J. 2021 Jun;35 (6) :e21664.|FASEB J. 2024 Jul 15;38 (13) :e23781.|Free Radic Biol Med. 2022 Aug 1:188:337-350.|Front Cell Dev Biol. 2021 Jun 21:9:671704.|Front Cell Dev Biol. 2021 Sep 20;9:712224.|Front Cell Dev Biol. 2023 May 10:11:1140717.|Front Genet. 2022 Jul 22:13:905395.|Front Med. 2021 Sep 23;8:746298.|Fundam Res. 2022 Jun 3;4 (6) :1506-1514.|Genes (Basel) . 2024 Oct 30;15 (11) :1400.|Genes (Basel) . 2024 Sep 13;15 (9) :1206.|Genome Biol. 2025 Jul 7;26 (1) :196.|Harvard Medical School LINCS LIBRARY|Hepatology. 2022 Oct;76 (4) :1046-1057.|Immunity. 2025 Apr 8;58 (4) :946-960.e10.|Int J Biol Sci. 2024 Sep 16;20 (12) :4999-5026.|Int J Biol Sci. 2021 Jun 26;17 (11) :2683-2702.|Int J Biol Sci. 2023 Jan 1;19 (1) :204-224.|Int J Mol Sci. 2022 Aug 12;23 (16) :9049.|Int J Mol Sci. 2022 Jul 8;23 (14) :7586.|Int J Mol Sci. 2022 Oct 14;23 (20) :12249.|Int J Mol Sci. 2023 Mar 22;24 (6) :6008.|Int J Mol Sci. 2023 Oct 31;24 (21) :15804.|Int J Mol Sci. 2024 Jul 27;25 (15) :8209.|Int J Mol Sci. 2025 May 31;26 (11) :5306.|Int J Oncol. 2026 Jan;68 (1) :8.|Int J Stem Cells. 2023 May 30;16 (2) :156-167.|Int J Surg. 2025 Nov 20.|Invest Ophthalmol Vis Sci. 2025 Jun 2;66 (6) :8.|iScience. 2022 Oct 6;25 (11) :105293.|iScience. 2023 Jul 26;26 (8) :107469.|iScience. 2025 Jun 26;28 (8) :113013.|J Appl Polym Sci. 2024 Sep 25.|J Biol Chem. 2022 Dec;298 (12) :102703.|J Biol Chem. 2024 Jan;300 (1) :105556.|J Biol Eng. 2024 Jan 16;18 (1) :7.|J Biomed Mater Res A. 2025 Oct;113 (10) :e38001.|J Cell Mol Med. 2019 Jul;23 (7) :4627-4639.|J Cell Mol Med. 2021 Nov;25 (22) :10684-10697.|J Cereb Blood Flow Metab. 2022 May;42 (5) :757-770.|J Dairy Sci. 2025 Sep;108 (9) :10248-10262.|J Exp Med. 2022 Nov 7;219 (11) :e20212405.|J Gene Med. 2025 May;27 (5) :e70021.|J Hazard Mater. 2023 Oct 5:459:132225.|J Int Med Res. 2021 Nov;49 (11) :3000605211055378.|JCI Insight. 2022 Jun 14; e158428.|Lab Invest. 2021 Sep;101 (9) :1130-1141.|Life Sci Alliance. 2022 Apr 19;5 (8) :e202201421.|Life Sci. 2020 Sep 1;256:117983.|Mater Today Bio. 2024 Jun 1:26:101111.|Mater Today Chem. aterials Today Chemistry 12 (2019) 78e84|MedComm (2020) . 2025 Sep 18;6 (10) :e70392.|Methods Mol Biol. 2024:2767:43-52.|Methods Mol Biol. 2024:2767:53-62.|Mil Med Res. 2020 Sep 6;7 (1) :42.|Mol Autism. 2025 Nov 27;16 (1) :60.|Mol Cancer. 2024 Jan 10;23 (1) :12.|Mol Carcinog. 2024 Oct;63 (10) :2013-2025.|Mol Cell. 2017 Mar 2;65 (5) :873-884.e8.|Mol Cell. 2022 Aug 4;82 (15) :2779-2796.e10.|Mol Med. 2024 Dec 20;30 (1) :260.|Mol Ther Nucleic Acids. 2021 May 29:26:22-33.|Mol Ther Nucleic Acids. 2025 Mar 7;36 (2) :102506.|Molecules. 2020 Apr 23;25 (8) :1980.|Nano Today. 2025 Apr.|Nat Chem Biol. 2020 Dec;16 (12) :1411-1419.|Nat Commun. 2022 Sep 6;13 (1) :5237.|Nat Commun. 2025 Aug 26;16 (1) :7954.|Nat Commun. 2025 Feb 25;16 (1) :1774.|Nat Commun. 2025 Jul 1;16 (1) :5540.|Nat Commun. 2025 Jul 1;16 (1) :6016.|Nat Commun. 2025 Mar 17;16 (1) :2635.|Nat Commun. 2025 Sep 30;16 (1) :8693.|Nat Genet. 2024 Feb;56 (2) :294-305.|Nat Immunol. 2025 Oct;26 (10) :1660-1672.|Nat Med. 2016 May;22 (5) :547-56. |Nat Metab. 2023 Jun;5 (6) :1014-1028.|Nat Struct Mol Biol. 2025 Sep 1.|Naturwissenschaften. 2025 Jul 23;112 (4) :53.|Norges teknisk-naturvitenskapelige universitet. 2025.|Nucleic Acids Res. 2021 Nov 18;49 (20) :11575-11595.|Nucleic Acids Res. 2022 Jul 22;50 (13) :7310-7325.|Nucleic Acids Res. 2025 Aug 11;53 (15) :gkaf785.|Oncol Lett. 2023 Aug 30;26 (4) :447.|Oxid Med Cell Longev. 2020 Nov 26;2020:4830418.|Patent. US20180263995A1.|Patent. US20210002607A1.|Patent. US20250129329A1.|Pigment Cell Melanoma Res. 2024 Jan;37 (1) :21-35.|PLoS Biol. 2019 Oct 15;17 (10) :e3000498.|PLoS Biol. 2024 Jul 23;22 (7) :e3002727.|Proc Natl Acad Sci U S A. 2019 Mar 12;116 (11) :4989-4998.|Programa de Doctorado en Biomedicina. 2020 Sep.|Redox Biol. 2025 Apr:81:103539.|Reprod Sci. 2025 May 29.|Res Sq. 2024 Jun 03.|Res Sq. 2024 May 20.|Res Sq. 2025 Apr 24.|Res Sq. 2025 Jul 14.|Res Sq. 2025 May 22.|Res Sq. 2025 Nov 10.|Res Sq. 2025 Sep 19.|Research Square Preprint. 2021 Feb.|Research Square Preprint. 2021 Nov.|Respir Res. 2022 Mar 25;23 (1) :70.|Rice University, Department of Biological Sciences. 2020 Apr.|Ruperto Carola University Heidelberg. Faculty of Natural Sciences and Mathematics. 03 Mar 2022.|Sci Adv. 2021 Apr 14;7 (16) :eabb2213.|Sci Adv. 2023 Dec 22;9 (51) :eadi5683.|Sci Adv. 2025 Oct 10;11 (41) :eady6410.|Sci China Life Sci. 2018 Oct;61 (10) :1151-1167.|Sci Rep. 2025 Feb 24;15 (1) :6636.|Sci Rep. 2025 Jan 7;15 (1) :1177.|Sci Rep. 2025 Sep 26;15 (1) :32986.|Sci Rep. 2019 Dec 10;9 (1) :18731. |SLAS Discov. 2024 Nov 5;29 (8) :100191.|Small. 2020 Jun;16 (22) :e2001371.|SSRN. 2023 Sep 1.|SSRN. 2025 Jul 25.|STAR Protoc. 2021 Nov 5;2 (4) :100881.|STAR Protoc. 2022 Jun 7;3 (2) :101426.|STAR Protoc. 2023 Feb 3;4 (1) :102092.|STAR Protoc. 2023 Mar 16;4 (2) :102151.|Stem Cell Reports. 2025 Jan 23:102398.|Stem Cell Res Ther. 2021 Mar 29;12 (1) :214.|Stem Cell Res Ther. 2022 Feb 2;13 (1) :48.|Stem Cell Res Ther. 2023 Jan 5;14 (1) :1.|Stem Cell Res Ther. 2024 Dec 3;15 (1) :463.|Stem Cell Res Ther. 2024 Oct 8;15 (1) :350.|Stem Cell Res Ther. 2025 May 13;16 (1) :239.|Stem Cell Res Ther. 2025 Nov 13;16 (1) :636.|Stem Cell Res Ther. 2025 Oct 8;16 (1) :547.|Stem Cell Res Ther. 2020 Apr 16;11 (1) :157.|Stem Cells Int. 2018 Dec 25:2018:5965727.|Stem Cells Int. 2020 Feb 3;2020:8483035.|Stem Cells Int. 2025 Jul 11:2025:5105796.|Stem Cells Transl Med. 2021 May;10 (5) :743-755.|Stem Cells. 2019 Apr;37 (4) :489-503.|Stem Cells. 2022 Oct 21;40 (10) :892-905.|Theranostics. 2018 Jul 30;8 (15) :4262-4278.|Theranostics. 2019 Aug 12;9 (20) :5769-5783.|Tissue Eng Regen Med. 2025 Feb;22 (2) :249-260.|Toxicol Appl Pharmacol. 2020 Jan 1;386:114813.|Toxicol Appl Pharmacol. 2024 Nov 26:494:117175.|Toxicol Appl Pharmacol. 2025 May:498:117284.|Toxicology. 2016 Apr 29:355-356:31-8.|Toxicology. 2020 Apr 15;435:152422.|Toxins. 2021 Aug 22;13 (8) :585.|University of Otago. Biomedical Sciences. 2021 Nov.|UNIVERSITY OF PAVIA. 2023 Jul 9.|Zool Res. 2021 May 18;42 (3) :377-388.|bioRxiv. 2025 Aug 31.|Mol Cell Proteomics. 2025 May 12:100991.|Poult Sci. 2022 Jun;101 (6) :101825.|EMBO Mol Med. 2022 Dec 7;14 (12) :e16194.|J Transl Med. 2021 Oct 9;19 (1) :417.|Transl Oncol. 2024 Jul 5:47:102054.